VMD icon

Viemed Healthcare

6.78 USD
-0.14
2.02%
At close Updated Sep 12, 4:00 PM EDT
Pre-market
After hours
6.78
0.00
0%
1 day
-2.02%
5 days
-1.45%
1 month
-8.87%
3 months
0%
6 months
-13.19%
Year to date
-16.61%
1 year
-9.24%
5 years
-22.25%
10 years
-3.42%
 

About: Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

Employees: 1,258

0
Funds holding %
of 7,462 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

74% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 35

1.85% more ownership

Funds ownership: 62.89% [Q1] → 64.74% (+1.85%) [Q2]

2% less capital invested

Capital invested by funds: $181M [Q1] → $177M (-$4.06M) [Q2]

10% less funds holding

Funds holding: 139 [Q1] → 125 (-14) [Q2]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q1] → 2 (-1) [Q2]

59% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 22

Financial journalist opinion

Neutral
Seeking Alpha
1 month ago
Viemed Healthcare, Inc. (VMD) Q2 2025 Earnings Call Transcript
Viemed Healthcare, Inc. (NASDAQ:VMD ) Q2 2025 Earnings Conference Call August 7, 2025 11:00 AM ET Company Participants Casey Hoyt - CEO & Director Trae Paul Fitzgerald - Chief Financial Officer William Todd Zehnder - COO & Director Conference Call Participants Ilya Zubkov - Freedom Broker, Research Division Ryan M. Langston - TD Cowen, Research Division Operator Greetings, and welcome to the Viemed Healthcare Second Quarter 2025 Earnings Call.
Viemed Healthcare, Inc. (VMD) Q2 2025 Earnings Call Transcript
Neutral
The Motley Fool
1 month ago
Viemed (VMD) Q2 Revenue Rises 15%
Viemed (VMD) Q2 Revenue Rises 15%
Viemed (VMD) Q2 Revenue Rises 15%
Neutral
Accesswire
1 month ago
Viemed Healthcare Announces Second Quarter 2025 Financial Results
LAFAYETTE, LA / ACCESS Newswire / August 6, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today that it has reported its financial results for the three and six months ended June 30, 2025. Operational highlights (all dollar amounts are USD; comparisons are to the period ended June 30, 2024 unless otherwise noted): Net revenues for the quarter ended June 30, 2025 were $63.1 million, setting another Company record, representing an increase of $8.1 million, or 14.7%, over net revenues reported for the comparable quarter ended June 30, 2024.
Viemed Healthcare Announces Second Quarter 2025 Financial Results
Neutral
Accesswire
1 month ago
Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details
LAFAYETTE, LA / ACCESS Newswire / July 22, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, today announced that it will host its Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: (877) 407-6176 (US Toll-Free) +1 (201) 689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=4jnXGdPH Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details
Neutral
Accesswire
2 months ago
Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results
LAFAYETTE, LA / ACCESS Newswire / July 2, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has completed the previously disclosed acquisition of Illinois-based Lehan's Medical Equipment ("Lehan") for a base purchase price of $26 million, subject to customary adjustments, plus estimated contingent payments of $2.2 million. "We are pleased to close the acquisition of Lehan and bring this talented and highly motivated team into the Viemed family," said Viemed Chief Executive Officer Casey Hoyt.
Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results
Neutral
Seeking Alpha
4 months ago
Viemed Healthcare, Inc. (VMD) Q1 2025 Earnings Call Transcript
Viemed Healthcare, Inc. (NASDAQ:VMD ) Q1 2025 Earnings Conference Call May 8, 2025 11:00 AM ET Company Participants Casey Hoyt – Chief Executive Officer Trae Fitzgerald – Chief Financial Officer Todd Zehnder – Chief Operating Officer Conference Call Participants Brooks O'Neil – Lake Street Capital Ryan Langston – TD Cowen Andrew Rem – Odinson Partners Operator Good day, ladies and gentlemen, and welcome to the Viemed Healthcare First Quarter 2025 Earnings Call. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host, Trae Fitzgerald, CFO.
Viemed Healthcare, Inc. (VMD) Q1 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
4 months ago
Viemed Healthcare Announces First Quarter 2025 Financial Results
LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025.
Viemed Healthcare Announces First Quarter 2025 Financial Results
Neutral
GlobeNewsWire
4 months ago
Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois
LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has entered into a definitive agreement to acquire Illinois-based Lehan's Medical Equipment (“Lehan”), a healthcare company offering home medical equipment with specialties in respiratory care and women's health.
Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois
Neutral
GlobeNewsWire
4 months ago
Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details
LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025, at 11:00 a.m. EDT.
Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details
Positive
Seeking Alpha
4 months ago
Viemed Healthcare: Remaining Bullish Due To Strong Forward-Looking EPS Revisions
Viemed Healthcare's stock has declined recently, but bullish EPS revisions and strong growth projections make it an attractive buy near its long-term bottom. The company projects significant revenue and EBITDA growth for 2025, with EPS expected to rise by 42.86% in 2025 and 52.5% in 2026. Viemed's valuation remains attractive, with positive cash flow and rising equity, despite the stock's recent bearish trend.
Viemed Healthcare: Remaining Bullish Due To Strong Forward-Looking EPS Revisions
Charts implemented using Lightweight Charts™